Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Tonix Pharmaceuticals announced an agreement with a major group purchasing organization to provide commercial payer coverage for TONMYA® (cyclobenzaprine HCl sublingual tablets), a first-in-class FDA-approved non-opioid treatment for fibromyalgia in adults. The agreement grants access to around 35 million commercial lives in the U.S., representing …
Madrigal Pharmaceuticals announced first-quarter 2026 financial results demonstrating a 127% year-over-year increase in net sales of its key drug Rezdiffra, reaching $311.3 million. The company highlighted strong patient adoption, with over 42,250 patients on Rezdiffra, and expanded its pipeline through a global licensing agreement for a clinical-s…
Tempest Therapeutics announced clinical updates from its ongoing Phase 1 trials of TPST-2003, a dual-targeting CD19/BCMA CAR-T therapy. The updated data show a 100% complete response rate among 15 CAR-T-naïve efficacy evaluable patients treated in the REDEEM-1 and POEMS-1 trials for relapsed/refractory multiple myeloma and POEMS syndrome, respectiv…
Strata Critical Medical announced an 87.4% year-over-year revenue increase to $67.4 million in Q1 2026, driven by strong organic growth in its logistics segment and the addition of new clinical offerings following the Keystone acquisition. The company posted a net income of $2.4 million from continuing operations, improved gross margins, and strong…
Anavex Life Sciences Corp. has appointed former Senior VP of Clinical Development Terrie Kellmeyer, PhD, as Interim CEO after the resignation of Christopher Missling. Dr. Kellmeyer brings extensive experience in clinical development, regulatory affairs, and quality assurance and will focus on advancing Anavex's clinical programs, particularly its l…
The Brink's Company (NYSE: BCO) reported a robust first quarter financial performance for 2026, with 10% revenue growth including 4.5% organic growth and strong margins in high-growth segments like ATM managed services and digital retail. Operating cash flows increased, with free cash flow surpassing $500 million on a trailing-twelve-month basis fo…
Eupraxia Pharmaceuticals announced the first release of EoEHSS sub scores data from its ongoing Phase 1b/2a RESOLVE trial evaluating EP-104GI for treating eosinophilic esophagitis (EoE). The data showed significant improvements in esophageal tissue inflammation and fibrosis at both 12 and 36 weeks, especially at the highest dose cohort. These findi…
Hyperion DeFi, Inc., a Nasdaq-listed decentralized finance company, announced the pricing of a public offering of nearly 2.78 million common shares at $3.60 per share, expected to raise approximately $10 million. The proceeds are to be used to enhance its treasury strategy by acquiring additional HYPE tokens and for general corporate purposes. The …
TG Therapeutics reported strong first quarter 2026 financial results with total global revenue of $205 million, highlighted by a 63% increase in U.S. net revenue for BRIUMVI, its treatment for relapsing multiple sclerosis. The company raised its full-year 2026 revenue guidance to approximately $925 million globally and increased its BRIUMVI U.S. ne…
Aquestive Therapeutics will report its financial results for the first quarter ending March 31, 2026, on May 13, followed by an investor call on May 14. The company highlighted ongoing development programs including its Anaphylm™ sublingual film and AQST-108 topical gel, advancing treatments for severe allergic reactions and dermatological conditio…
GDS Holdings Limited, a leading developer and operator of high-performance data centers in China, will report its unaudited first quarter 2026 financial results on May 20, 2026, prior to U.S. market open. The company will host an earnings conference call on the same day for investors and analysts, providing insights into its financial performance a…
Climb Global Solutions (NASDAQ: CLMB) has announced a new exclusive North American distribution partnership with Dashlane, expanding access to Dashlane's Omnix credential security platform to U.S. and Canadian resellers. This collaboration aims to enhance enterprise security by proactively protecting employee credentials and accelerating Dashlane's…
Relmada Therapeutics, a clinical-stage biotech firm focusing on oncology and CNS therapies, will report its first quarter 2026 financial results on May 12, 2026, and host a conference call to discuss recent business progress and financial performance.
Advantage Solutions Inc. delivered a solid first quarter with revenues increasing 5.8% to $869.6 million and Adjusted EBITDA growing 16.4% to $67.7 million, driven primarily by strong performance in Experiential Services and improved profitability in Retailer Services. Despite a net loss widening to $71.8 million due to higher expenses and non-cash…
J & J Snack Foods Corp. reported its fiscal 2026 second quarter results with net sales decreasing by 3.2% year-over-year to $344.8 million primarily due to expected declines in the bakery segment. Despite lower sales, gross profit improved by 3.8% and gross margin expanded. Operating income decreased substantially due to non-recurring plant closure…
Astec Industries, Inc. announced first quarter 2026 financial results with a 20.3% increase in net sales reaching $396.3 million, driven primarily by a 70.6% rise in Materials Solutions net sales. Despite the sales growth, net income declined sharply to $1.3 million from $14.3 million the prior year, affected by timing and mix shifts in Infrastruct…
Intchains Group Limited, a Nasdaq-listed company specializing in altcoin mining and staking services, announced it will shift its financial reporting frequency from quarterly to semi-annual starting fiscal year 2026. The change aims to better align with global market practices while maintaining compliance with SEC regulations. The company will cont…
Perma-Fix Environmental Services, Inc. reported first quarter 2026 financial results reflecting a transitional period with reduced revenues and operating losses due to seasonal softness and investments preparing for increased activity, especially related to Hanford waste projects, Nuclear Services mobilization, and PFAS technology expansion. Despit…
Royalty Pharma plc reported 10% growth in Portfolio Receipts to $925 million and 13% growth in Royalty Receipts to $887 million in Q1 2026. The company announced up to $1.25 billion in royalty transactions including R&D co-funding deals with Johnson & Johnson and Teva. Positive clinical developments in its portfolio products and strengthened capabi…
Steven Madden, Ltd. announced first quarter 2026 results with an 18% revenue increase driven by strong brand momentum and direct-to-consumer growth. The company raised its fiscal 2026 revenue guidance to a 10-12% increase and introduced earnings per share guidance between $2.55 and $2.65, signaling confidence in top- and bottom-line growth despite …
UBS upgraded its rating on Galenica from "sell" to "neutral" while leaving its CHF85 price target intact. The target sits slightly above the stock's current trading level of CHF82.05, implying roughly 4% upside. The broker's move follows about a 20% fall in the share price since late February and reflects UBS's revised assessment of buy-side sentim…
Global markets rallied after media reports suggested the United States and Iran are close to agreeing a one-page memorandum that would include unblocking the Strait of Hormuz. Oil prices fell sharply, while equity indexes from Wall Street to Asia hit fresh highs on hopes of reduced Gulf tensions and stronger AI-driven demand. At the same time, long…
Natural Resource Partners L.P. released its first quarter 2026 financial results, highlighting $19.6 million in net income and declaring a $0.75 per common unit distribution. The company generated $33.8 million in free cash flow before a $39.2 million investment in its soda ash business. Though facing headwinds from weak coal sales volumes and over…
Passive, long-only vehicles bought $12.0 billion of emerging-market equities in April, with Taiwan, Brazil and China the largest recipients of inflows, Morgan Stanley reports. Active foreign managers were net sellers. Hedge funds concentrated exposure in Information Technology across Asia ex-Japan, while long-only investors adjusted regional and se…
Walt Disney reported adjusted earnings-per-share of $1.57 and revenue of $25.2 billion for the January-March quarter, beating analysts' expectations. New CEO Josh D'Amaro, in a letter to shareholders, reaffirmed the company’s outlook for accelerated adjusted EPS growth in fiscal 2026 and sustained double-digit growth into fiscal 2027, while outlini…
